Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study
Transplant International · 2025
DOI: 10.3389/ti.2025.14342 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant International, 2025. Verfasst von Nassim Kamar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Institut national de la santé et de la recherche médicale …. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus Infections, Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp and Dohme France.
Abstract (Originalsprache)
The incidence of leukopenia and neutropenia associated with cytomegalovirus (CMV) prophylaxis in kidney transplant (KT) recipients is not well established. LECOCYT, a prospective observational multicenter study, aimed to investigate the clinical and economic burdens of CMV prophylaxis during the first 6 months post-transplantation. Grade 3 or 4 leukopenia or neutropenia was assessed in CMV-seropositive donors/CMV-seronegative recipients (D+/R-) who received current anti-CMV prophylaxis, and in CMV-seronegative donors/CMV-seronegative recipients (D-/R-) who did not. The economic burden in D+/R- was also evaluated. The adjusted odds ratio for grade 3 or 4 leukopenia or neutropenia was 5.16 [95% confidence interval: 1.97–13.53] for D+/R- group. The median costs, excluding the KT procedure, for D+/R- subgroup patients who experienced at least one episode of severe leukopenia or neutropenia were approximately €4,500 (Q1 = €561; Q3 = €10,000). D+/R- patients with no episode incurred significantly lower costs, with a median of nearly €2,100 (Q1 = €182; Q3 = €6,500) (p = 0.02). D+/R- patients with severe leukopenia or neutropenia had a higher rate of outpatient consultations than those without episode (73.9% vs. 57.6%, p = 0.002), and a higher average number of consultations per patient (5.5 ± 4.1 vs. 4.5 ± 3.3, p = 0.042) than D+/R- patients without. Anti-CMV prophylaxis in D+/R- transplant recipients was significantly associated with a higher rate of severe leukopenia or neutropenia compared to no prophylaxis in D-/R- recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Institut national de la santé et de la recherche médicale - Unité Mixte de Recherche 1291 (INSERM UMR 1291), Toulouse Institute…
- Department of Nephrology-Transplantation-Dialysis-Apheresis, University Hospital of Bordeaux, Bordeaux, France.
- Department of Nephrology, Institut de Transplantation Urologie-Nephrologie (ITUN), Nantes University Hospital, Nantes, France.
- MSD France, Puteaux, France.
- ClinSearch, Malakoff, France.
- Unité de Recherche Clinique en Économie de la Santé d'Ile de France (URC-Eco), Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.
Förderung
- Merck Sharp and Dohme France
Zitieren
APA
Kamar, N., Kaminski, H., Masset, C., Castagné, C., Tournaire, G., Bourge, X., Bensimon, L., Naja, M., Degroote, S., Durand-Zaleski, I., & Legendre, C. (2025). Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study. Transplant International. https://doi.org/10.3389/ti.2025.14342
Vancouver
Kamar N, Kaminski H, Masset C, Castagné C, Tournaire G, Bourge X, et al. Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study. Transplant International. 2025. doi:10.3389/ti.2025.14342
BibTeX
@article{Kamar2025,
author = {Kamar, Nassim and Kaminski, Hannah and Masset, Christophe and Castagné, Claire and Tournaire, Guilhem and Bourge, Xavier and Bensimon, Lionel and Naja, Moustafa and Degroote, Stéphanie and Durand-Zaleski, Isabelle and Legendre, Christophe},
title = {Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study},
journal = {Transplant International},
year = {2025},
doi = {10.3389/ti.2025.14342}
}
EUVIMED